# A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants

> **NCT04023877** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 8 (actual)

## Conditions studied

- Dementias With Lewy Bodies

## Interventions

- **DRUG:** E2027

## Key facts

- **NCT ID:** NCT04023877
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2019-10-11
- **Final completion:** 2019-10-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023877, "A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04023877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*